Concepedia

Author

Oliver R. Mikse

Harvard University

Also Known As

Chen, Liang, Lynette M. Sholl, O Mikse, O. Mikse, Oliver Mikse, Oliver R. Mikse, Sholl, Lynette M.

69

Publications

1.9K

Citations

10

H-Index

39

Concepts

All Affiliations

Harvard UniversityPennsylvania State UniversityDana-Farber Cancer InstituteBroad InstituteBrigham and Women's Hospital
OR

About

Oliver R. Mikse is an author at Harvard University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

490

2

Cell Biology

5

5

474

3

Social Sciences

1

1

16

4

Biology

1

1

16

5

Neurology

1

1

299

Oliver R. Mikse

×

9

Publications

1.8K

Citations

9

H-Index

YearCitations

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

Esra A. Akbay, Shohei Koyama, Julián Carretero,

Cancer Discovery

2013

1.2K

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice

Koji Yamanaka, Séverine Boillée, Elizabeth A. Roberts,

Proceedings of the National Academy of Sciences

2008

299

Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

Jun Wang, Oliver R. Mikse, Rachel G. Liao,

Oncogene

2014

69

Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss

Michael T. Debies, Shelley A. Gestl, Jessica L. Mathers,

Journal of Clinical Investigation

2008

62

Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in <i>ALK</i> -Rearranged Non–Small Cell Lung Cancer and Predict Strategies to Overcome Resistance

Zhao Chen, Esra A. Akbay, Oliver R. Mikse,

Clinical Cancer Research

2013

60

<i>FOXO3</i> Encodes a Carcinogen-Activated Transcription Factor Frequently Deleted in Early-Stage Lung Adenocarcinoma

Oliver R. Mikse, Daniel C. Blake, Nathan R. Jones,

Cancer Research

2010

41

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Jeremy H. Tchaicha, Esra A. Akbay, Abigail Altabef,

Cancer Research

2014

38

FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK)

Daniel C. Blake, Oliver R. Mikse, Willard M. Freeman,

Lung Cancer

2009

27

Variation of the neurofilament medium KSP repeat sub-domain across mammalian species: implications for altering axonal structure

Devin M. Barry, Catherine L. Carpenter, C. Yager,

Journal of Experimental Biology

2009

16

Page 1